Barclays PLC Magenta Therapeutics, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023
SELL
$0.41 - $0.86 $2,160 - $4,531
-5,269 Reduced 99.02%
52 $0
Q4 2022

Feb 13, 2023
SELL
$0.36 - $1.59 $693 - $3,062
-1,926 Reduced 26.58%
5,321 $2,000
Q3 2022

Nov 03, 2022
SELL
$1.26 - $2.09 $1,762 - $2,923
-1,399 Reduced 16.18%
7,247 $10,000
Q2 2022

Aug 12, 2022
SELL
$0.97 - $3.08 $4,451 - $14,134
-4,589 Reduced 34.67%
8,646 $10,000
Q1 2022

May 16, 2022
SELL
$2.55 - $5.23 $80,212 - $164,514
-31,456 Reduced 70.39%
13,235 $38,000
Q4 2021

Feb 14, 2022
BUY
$4.43 - $8.33 $106,674 - $200,586
24,080 Added 116.83%
44,691 $198,000
Q3 2021

Nov 09, 2021
SELL
$6.07 - $9.89 $34,374 - $56,007
-5,663 Reduced 21.55%
20,611 $151,000
Q2 2021

Aug 13, 2021
SELL
$9.76 - $14.15 $86,249 - $125,043
-8,837 Reduced 25.17%
26,274 $257,000
Q1 2021

May 13, 2021
SELL
$7.66 - $13.38 $27,338 - $47,753
-3,569 Reduced 9.23%
35,111 $415,000
Q4 2020

Feb 11, 2021
BUY
$6.1 - $7.94 $25,967 - $33,800
4,257 Added 12.37%
38,680 $304,000
Q3 2020

Nov 12, 2020
BUY
$6.52 - $8.94 $82,230 - $112,751
12,612 Added 57.82%
34,423 $233,000
Q2 2020

Aug 12, 2020
BUY
$6.18 - $10.76 $81,359 - $141,655
13,165 Added 152.27%
21,811 $164,000
Q1 2020

May 13, 2020
SELL
$6.03 - $15.24 $64,074 - $161,940
-10,626 Reduced 55.14%
8,646 $55,000
Q4 2019

Feb 10, 2020
BUY
$9.07 - $15.84 $82,890 - $144,761
9,139 Added 90.19%
19,272 $292,000
Q3 2019

Nov 14, 2019
SELL
$9.63 - $14.0 $60,303 - $87,668
-6,262 Reduced 38.19%
10,133 $104,000
Q2 2019

Aug 14, 2019
BUY
$13.4 - $17.67 $108,540 - $143,127
8,100 Added 97.65%
16,395 $242,000
Q1 2019

May 15, 2019
BUY
$5.7 - $19.7 $32,170 - $111,186
5,644 Added 212.9%
8,295 $137,000
Q4 2018

Feb 14, 2019
BUY
$5.57 - $11.65 $6,344 - $13,269
1,139 Added 75.33%
2,651 $15,000
Q3 2018

Nov 14, 2018
BUY
$11.32 - $15.7 $17,115 - $23,738
1,512 New
1,512 $18,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email